This inventor holds 1 USPTO granted patent. Top assignee: Gilead Sciences, Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Murty N Arimili: Innovator in HIV Therapeutics
Introduction
Murty N Arimili is a notable inventor based in Oak Ridge, NC (US). He has made significant contributions to the field of antiviral therapeutics, particularly in the development of compounds that inhibit HIV protease activity. His work is crucial in the ongoing fight against AIDS and other viral infections.
Latest Patents
Murty N Arimili holds a patent for "Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds." This patent discloses phosphonate substituted compounds with HIV protease inhibitory properties. These compounds are not only useful therapeutically for the treatment of AIDS but also serve industrial purposes. The compositions developed by Arimili inhibit HIV protease activity and are valuable in assays for the detection of HIV protease.
Career Highlights
Arimili is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company focused on developing innovative medicines. His work at Gilead has allowed him to contribute to groundbreaking research in antiviral therapies.
Collaborations
Some of his notable coworkers include Xiaowu Chen and Maria Fardis, who have collaborated with him on various projects related to HIV therapeutics.
Conclusion
Murty N Arimili's innovative work in the field of HIV protease inhibitors highlights his commitment to advancing medical science. His contributions are vital in the development of effective treatments for viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile